Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724115 | SCV000225522 | uncertain significance | not provided | 2014-10-17 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000194168 | SCV000246758 | likely benign | not specified | 2015-05-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001084811 | SCV000762447 | benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724115 | SCV001826903 | likely benign | not provided | 2019-03-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002321688 | SCV002632674 | benign | Inborn genetic diseases | 2017-10-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV000724115 | SCV001978018 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000724115 | SCV001980431 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001084811 | SCV002087282 | likely benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2020-03-04 | no assertion criteria provided | clinical testing |